CU20100175A7 - IMIDAZO DERIVATIVES- [1,2-B] -PIRIDAZINE FOR THE TREATMENT OF DISEASE MEASURED BY C-MET THYROSINE KINASE - Google Patents
IMIDAZO DERIVATIVES- [1,2-B] -PIRIDAZINE FOR THE TREATMENT OF DISEASE MEASURED BY C-MET THYROSINE KINASEInfo
- Publication number
- CU20100175A7 CU20100175A7 CU20100175A CU20100175A CU20100175A7 CU 20100175 A7 CU20100175 A7 CU 20100175A7 CU 20100175 A CU20100175 A CU 20100175A CU 20100175 A CU20100175 A CU 20100175A CU 20100175 A7 CU20100175 A7 CU 20100175A7
- Authority
- CU
- Cuba
- Prior art keywords
- treatment
- formula
- met
- piridazine
- compound
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a los compuestos de la fórmula (I) y sales de los mismos: en donde los sustituyentes son como se definen en la memoria descriptiva, a la aplicación de un compuesto de la fórmula (I) en un proceso para el tratamiento del cuerpo humano o animal, en particular con respecto una enfermedad mediada por la cinasa de tirosina c-Met; al uso de un compuesto de la fórmula (I) para la fabricación de un medicamento para el tratamiento de estas enfermedades; a composiciones farmacéuticas que comprenden un compuesto de la fórmula (I), opcionalmente en la presencia de un componente de combinación; y a procesos para la preparación de un compuesto de la fórmula (I).The invention relates to the compounds of the formula (I) and salts thereof: wherein the substituents are as defined in the specification, to the application of a compound of the formula (I) in a process for the treatment of the human or animal body, in particular with respect to a disease mediated by c-Met tyrosine kinase; to the use of a compound of the formula (I) for the manufacture of a medicament for the treatment of these diseases; to pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination component; and to processes for the preparation of a compound of the formula (I).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20100175A CU20100175A7 (en) | 2010-08-26 | 2010-08-26 | IMIDAZO DERIVATIVES- [1,2-B] -PIRIDAZINE FOR THE TREATMENT OF DISEASE MEASURED BY C-MET THYROSINE KINASE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20100175A CU20100175A7 (en) | 2010-08-26 | 2010-08-26 | IMIDAZO DERIVATIVES- [1,2-B] -PIRIDAZINE FOR THE TREATMENT OF DISEASE MEASURED BY C-MET THYROSINE KINASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20100175A7 true CU20100175A7 (en) | 2011-10-31 |
Family
ID=45000129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20100175A CU20100175A7 (en) | 2010-08-26 | 2010-08-26 | IMIDAZO DERIVATIVES- [1,2-B] -PIRIDAZINE FOR THE TREATMENT OF DISEASE MEASURED BY C-MET THYROSINE KINASE |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20100175A7 (en) |
-
2010
- 2010-08-26 CU CU20100175A patent/CU20100175A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2010000263A (en) | IMIDAZO DERIVATIVES- [1,2-B] -PIRIDAZINE FOR THE TREATMENT OF DISEASE MEASURED BY C-MET THYROSINE KINASE | |
| CO6382119A2 (en) | VEGF-R2 PIRIDYLOXI-INDOLES INHIBITORS AND USE OF THE SAME FOR THE TREATMENT OF DISEASES | |
| IN2012DN01453A (en) | ||
| UY32829A (en) | DERIVATIVES OF 3-HETEROARIL-METIL-IMIDAZO- [1,2-B] -PIRIDIDAZIN - 6 -ILO | |
| DOP2010000012A (en) | PYRIMIDINE MORFOLINE DERIVATIVES USED IN DISEASES RELATED TO MTOR QUINASA AND / OR PI3K | |
| EA201200260A1 (en) | HETEROCYCLIC HYDRAZONES AND THEIR APPLICATION FOR THE TREATMENT OF CANCER AND INFLAMMATION | |
| CR20130588A (en) | HALOGENOALQUIL-1,3-OXAZINAS AS INHIBITORS OF THE BACE1 AND / OR BACE 2 | |
| HN2010002030A (en) | HYDROXIMETHYL PIRROLIDINS AS AGONISTS OF THE BETA 3 ADRENERGIC RECEIVER | |
| ECSP10010685A (en) | SALTS OF 2-FLUORO-N-METIL-4- [7- (QUINOLIN-6-IL-METIL) -IMIDAZO [1,2-B] [1,2,4] TRIAZIN-2-IL] BENZAMIDA AND RELATED PROCESSES WITH THE PREPARATION OF THE SAME | |
| CL2012000589A1 (en) | Compounds derived from pyrrolo pyridine carboxamides, jak2 inhibitors; pharmaceutical composition comprising them; use in the treatment of myeloproliferative diseases or cancer, such as polycythemia vera, essential thrombocytopenia, multiple myeloma, among others. | |
| ECSP12011716A (en) | (HETEROARILMETIL) SUBSTITUTED THIOHYDANTOINS AS ANTI-CANCER DRUGS | |
| CR20130432A (en) | 1,3-OXAZINES AS INHIBITORS OF THE BACE1 AND / OR THE BACE2 | |
| CR11201A (en) | DERIVATIVES OF PIRIMIDINE TRISUSTITUIDA FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
| UY30282A1 (en) | CHEMICAL COMPOUNDS | |
| DOP2015000169A (en) | TETRACYCLIC COMPOUNDS REPLACED WITH HETEROCICLE AND USES OF THE SAME FOR THE TREATMENT OF VIVIC DISEASES | |
| UY34955A (en) | 4-METHYL-2,3,5,9,9B-PENTAAZA-CICLOPENTA [A] NAFTALENOS | |
| MX339302B (en) | 6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase. | |
| UY31805A (en) | AGONISTS M1, PHARMACEUTICAL COMPOSITIONS OF THE SAME, PROCESSES FOR THEIR PREPARATION AND ITS USES FOR THE TREATMENT OF PAIN | |
| UY31812A (en) | CINOLINE DERIVATIVES AS CSF-1 INHIBITORS | |
| CU20100175A7 (en) | IMIDAZO DERIVATIVES- [1,2-B] -PIRIDAZINE FOR THE TREATMENT OF DISEASE MEASURED BY C-MET THYROSINE KINASE | |
| CU20100004A7 (en) | PYRIMIDINE MORFOLINE DERIVATIVES USED IN DISEASES RELATED TO MTOR QUINASA AND / OR PI3K | |
| TN2010000390A1 (en) | Imidazo[1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease | |
| CU20100003A7 (en) | PIRIMIDINE TRISUSTITUTE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
| CU20100005A7 (en) | DERIVATIVES OF PIRIMIDINE TRISUSTITUIDA FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
| CU20140021A7 (en) | DERIVATIVES OF 2- AMINO-4- (PIRIDIN-2-IL) -5,6- DIHIDRO-4H-1,3- OXACINE AND ITS USE AS BACE -1 AND / OR BACE-2 INHIBITORS |